최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Carbohydrate polymers, v.230, 2020년, pp.115568 -
Lee, Jae-Young (College of Pharmacy, Chungnam National University) , Lee, Han Sol (College of Pharmacy, Chungnam National University) , Kang, Nae-Won (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University) , Lee, Song Yi (College of Pharmacy, Kangwon National University) , Kim, Dong Hyun (College of Pharmacy, Chungnam National University) , Kim, Sungyun (College of Pharmacy, Kangwon National University) , Yoon, In-Soo (Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University) , Cho, Hyun-Jong (College of Pharmacy, Kangwon National University) , Kim, Dae-Duk (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Abstract Chondroitin sulfate A-deoxycholic acid-polyethylene glycol-maleimide (CSA-DOCA-PEG-MAL; CDPM) nanostructures were designed for the transient binding of MAL with thiol in blood components and cell membranes, in addition to the CD44 receptor targeting, for the therapy of breast cancer. The s...
Laboratory Investigation Ackerman 9 356 1960 Histochemical localization of sulfhydryl groups in the cells of normal human blood and bone marrow
Biomacromolecules Carvalho 19 2991 2018 10.1021/acs.biomac.8b00561 Redox-responsive micellar nanoparticles from glycosaminoglycans for CD44 targeted drug delivery
Biomaterials Cho 32 7181 2011 10.1016/j.biomaterials.2011.06.028 Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel
Biomaterials Cho 33 1190 2012 10.1016/j.biomaterials.2011.10.064 Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin
Journal of Pharmaceutical Investigation Choi 48 43 2018 10.1007/s40005-017-0370-4 Nanomedicines: Current status and future perspectives in aspect of drug delivery and pharmacokinetics
Science Translational Medicine Chow 5 216rv4 2013 10.1126/scitranslmed.3005872 Cancer nanomedicine: From drug delivery to imaging
Journal of Controlled Release Danhier 148 135 2010 10.1016/j.jconrel.2010.08.027 To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
ACS Nano Doolittle 9 8012 2015 10.1021/acsnano.5b01552 Spatiotemporal targeting of a dual-ligand nanoparticle to cancer metastasis
Analytical Biochemistry Ellman 93 98 1979 10.1016/S0003-2697(79)80122-0 A precise method for the determination of whole blood and plasma sulfhydryl groups
Journal of Controlled Release Ernsting 172 782 2013 10.1016/j.jconrel.2013.09.013 Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles
Analytical Biochemistry Eyer 312 224 2003 10.1016/S0003-2697(02)00506-7 Molar absorption coefficients for the reduced Ellman reagent: Reassessment
Advanced Drug Delivery Reviews Fang 63 136 2011 10.1016/j.addr.2010.04.009 The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
Bioconjugate Chemistry Fontaine 26 145 2015 10.1021/bc5005262 Long-term stabilization of maleimide-thiol conjugates
ACS Applied Materials & Interfaces Fu 11 1841 2019 10.1021/acsami.8b18664 Dual-modified novel biomimetic nanocarriers improve targeting and therapeutic efficacy in glioma
The American Journal of the Medical Sciences Hardin 228 73 1954 10.1097/00000441-195407000-00009 Studies on the sulfhydryl content of human leukocytes and erythrocytes
Journal of Pharmaceutical Investigation Hong 48 3 2018 10.1007/s40005-017-0356-2 Mesoporous silica-based nanoplatforms for the delivery of photodynamic therapy agents
Trends in Biochemical Sciences Hong 28 210 2003 10.1016/S0968-0004(03)00057-4 Disulfide bonds as switches for protein function
ACS Applied Materials & Interfaces Huang 11 22171 2019 10.1021/acsami.9b05827 Small, traceable, endosome-disrupting, and bioresponsive click nanogels fabricated via microfluidics for CD44-targeted cytoplasmic delivery of therapeutic proteins
Journal of Pharmaceutical Investigation Hwang 48 143 2018 10.1007/s40005-017-0377-x Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy
Nanoscale Jang 7 18584 2015 10.1039/C5NR05067G The synergistic effect of folate and RGD dual ligand of nanographene oxide on tumor targeting and photothermal therapy in vivo
Advanced Drug Delivery Reviews Janib 62 1052 2010 10.1016/j.addr.2010.08.004 Imaging and drug delivery using theranostic nanoparticles
Acta Biomaterialia Jeong 53 414 2017 10.1016/j.actbio.2017.02.030 Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration
Acta Pharmaceutica Sinica B Kalepu 5 442 2015 10.1016/j.apsb.2015.07.003 Insoluble drug delivery strategies: Review of recent advances and business prospects
International Journal of Biological Macromolecules Kang 125 61 2019 10.1016/j.ijbiomac.2018.12.028 Polyethylene glycol-decorated doxorubicin/carboxymethyl chitosan/gold nanocomplex for reducing drug efflux in cancer cells and extending circulation in blood stream
Advanced Drug Delivery Reviews Kemp 98 3 2016 10.1016/j.addr.2015.10.019 "Combo" nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy
Cancer Science Kenmotsu 106 497 2015 10.1111/cas.12647 Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose
Nanomaterials (Basel) Kim 7 E354 2017 10.3390/nano7110354 Doxorubicin-wrapped zinc oxide nanoclusters for the therapy of colorectal adenocarcinoma
Journal of Controlled Release Lammers 161 175 2012 10.1016/j.jconrel.2011.09.063 Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Journal of Pharmaceutical Investigation Le 48 527 2018 10.1007/s40005-018-0399-z Nano delivery systems and cancer immunotherapy
Journal of Pharmaceutical Investigation Lee 48 209 2018 10.1007/s40005-018-0387-3 Recent advances in quantum dots for biomedical applications
European Journal of Pharmaceutics and Biopharmaceutics Lee 94 532 2015 10.1016/j.ejpb.2015.06.011 Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery
Advanced Functional Materials Lee 25 3705 2015 10.1002/adfm.201500680 Phenylboronic acid-decorated chondroitin sulfate A-based theranostic nanoparticles for enhanced tumor targeting and penetration
Biomaterials Lee 85 218 2016 10.1016/j.biomaterials.2016.01.060 Iodinated hyaluronic acid oligomer-based nanoassemblies for tumor-targeted drug delivery and cancer imaging
International Journal of Nanomedicine Lee 9 2803 2014 Poly(styrene)-b-poly(DL-lactide) copolymer-based nanoparticles for anticancer drug delivery
Journal of Controlled Release Lee 236 38 2016 10.1016/j.jconrel.2016.06.021 Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery
Carbohydrate Polymers Lee 151 68 2016 10.1016/j.carbpol.2016.05.043 Polyethylene glycol-conjugated chondroitin sulfate A derivative nanoparticles for tumor-targeted delivery of anticancer drugs
Acta Biomaterialia Lee 57 262 2017 10.1016/j.actbio.2017.05.012 Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery
ACS Applied Materials & Interfaces Lee 9 22308 2017 10.1021/acsami.7b06582 Mussel-inspired hyaluronic acid derivative nanostructures for improved tumor targeting and penetration
Drug Delivery Lee 25 738 2018 10.1080/10717544.2018.1446476 An α-tocopheryl succinate enzyme-based nanoassembly for cancer imaging and therapy
Biomacromolecules Lee 20 835 2019 10.1021/acs.biomac.8b01449 Mitochondria targeting and destabilizing hyaluronic acid derivative-based nanoparticles for the delivery of lapatinib to triple-negative breast cancer
ACS Applied Materials & Interfaces Lee 10 36628 2018 10.1021/acsami.8b08243 Tumor targeting and lipid rafts disrupting hyaluronic acid-cyclodextrin-based nanoassembled structure for cancer therapy
International Journal of Nanomedicine Li 8 3855 2013 A novel application of maleimide for advanced drug delivery: In vitro and in vivo evaluation of maleimide-modified pH-sensitive liposomes
International Journal of Nanomedicine Li 9 2849 2014 Enhanced cellular uptake of maleimide-modified liposomes via thiol-mediated transport
Journal of Drug Targeting Negi 20 561 2012 10.3109/1061186X.2012.702767 Role of CD44 in tumour progression and strategies for targeting
International Journal of Nanomedicine Park 12 7453 2017 10.2147/IJN.S147668 Poly((D,L)lactic-glycolic)acid-star glucose nanoparticles for glucose transporter and hypoglycemia-mediated tumor targeting
Journal of Controlled Release Park 174 98 2014 10.1016/j.jconrel.2013.11.016 Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery
ACS Nano Phua 13 4742 2019 10.1021/acsnano.9b01087 Catalase-integrated hyaluronic acid as nanocarriers for enhanced photodynamic therapy in solid tumor
Molecular Pharmaceutics Platt 5 474 2008 10.1021/mp800024g Anticancer therapeutics: Targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor
Chemistry Ravasco 25 43 2019 10.1002/chem.201803174 Bioconjugation with maleimides: A useful tool for chemical biology
International Journal of Pharmaceutics Termsarasab 464 127 2014 10.1016/j.ijpharm.2014.01.015 Polyethylene glycol-modified arachidyl chitosan-based nanoparticles for prolonged blood circulation of doxorubicin
Advanced Drug Delivery Reviews Xie 62 1064 2010 10.1016/j.addr.2010.07.009 Nanoparticle-based theranostic agents
Small Xu 14 2018 10.1002/smll.201803601 Quinic acid-conjugated nanoparticles enhance drug delivery to solid tumors via interactions with endothelial selectins
Biomacromolecules Zhong 15 1955 2014 10.1021/bm5003009 Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.